References
Allen RC, Losse LD (1976) Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages. Biochem Biophys Res Commun 69:245–252
Broek H (1980) Treatment of Pruriga nodularis with thalidomide. Arch Dermatol 116:571–572
Faure M, Thivolet J, Gaucherand M (1980) Inhibition of PMN leukocytes chemotaxis by thalidomide. Arch Dermatol Res 269:275–280
Goihman-Yahr M, Convit J, Rodriguez-Ochoa G, Aranzazu N, Villalba-Pimentel L, Ocanto A, Goméz ME (1978) Significance of neutrophil activation in reactional lepromatous leprosy: Effects of thalidomide in vivo and in vitro. Activation in adjuvant disease. Int Arch Allergy Appl Immunol 57:317–332
Hastings RC, Morales MJ (1978) The effect of thalidomide on neutrophil function. Int J Lepr 46:120
Klebanoff SJ, Rosen H (1978) Ethylene formation by polymorphonuclear leukocytes. J Exp Med 148:490–506
Knop J, Happle R, Bonsmann G, Vakilzadeh F, Macher E (1981) Treatment of chronic discoid lupus erythematosus with thalidomide. Arch Dermatol Res 271:165–170
Mascaro JM, Lecha M, Torras H (1979) Thalidomide in the treatment of recurrent, necrotic, and giant mucocutaneous aphatae and aphtosis. Arch Dermatol 115:636–637
Massey V (1959) The microestimation ofsuccinate and the extinction coefficient of cytochrome C. Biochem Biophys Acta 34:255–256
McCord JM (1974) Free radicals and inflammation: Protection of synovial fluids by superoxide dismutase. Science 185:529–531
Miyachi Y, Takigawa M, Imamura S (1981) Suppression of DNCB-induced irritant dermatitis by colchicine. Acta Derm Venereol (Stockh) 61307–311
Miyachi Y, Danno K, Imamura S (1981) Suppression of active Arthus reaction by colchicine. Br J Dermatol 105:279–283
Miyachi Y, Ozaki M (1981) Thalidomide does not affect polymorphonuclear leukocyte (PMN) chemotaxis. Jpn J Lepr 50:62–64
Miyachi Y, Niwa Y (1982) Effects of potassium iodide, colchicine and dapsone on the generation of polymorphonuclear leukocyte-derived oxygen intermediates. Br J Dermatol 107:209–214
Miyachi Y, Yanase K, Imamura S, Niwa Y (1982) Increased hydroxyl radical generation by normal polymorphonuclear leukocytes incubated in sera from patients with leukocytoclastic vasculitis. Arch Dermatol Res 274
Moran CJ, Ryder G, Turk JL, Waters MFR (1972) Evidence for circulating immune complexes in lepromatous leprosy. Lancet II:572–573
Root RK, Metcalf JA (1977) H2O2 release from human granulocytes during phagocytosis. J Clin Invest 60:1266–1279
Salin ML, McCord JM (1975) Free radicals and inflammation: Protection of phagocytosing leukocytes by superoxide dismutase. J Clin Invest 56:1319–1323
Saul A, Flores O, Novales J (1976) Polymorphous light eruption: Treatment with thalidomide. Aust J Dermatol 17:17–21
Sheskin J (1965) Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 6:303–308
Sheskin J (1976) Thalidomide in lepra reaction. Int J Dermatol 14:575–576
Turk JL (1976) Leprosy as a model of subacute and chronic immunologic diseases. J Invest Dermatol 67:457–463
Ulrich M, Salas B, Convit J (1971) Thalidomide activity in experimental arthus and anaphylactic reactions. Int J Lepr 39:131–135
Waters MFR, Laing ABC, Ambikapathy A, Lennard-Jones JE (1979) Treatment of ulcerative colitis with thalidomide. Br Med J 24:792
Wemambu SNC, Turk JL, Waters MFR, Rees RJW (1969) Erythema nodosum leprosum: A clinical manifestation of the Arthus phenomenon. Lancet II:933–935
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miyachi, Y., Ozaki, M., Uchida, K. et al. Effects of thalidomide on the generation of oxygen intermediates by zymosan-stimulated normal polymorphonuclear leukocytes. Arch Dermatol Res 274, 363–367 (1982). https://doi.org/10.1007/BF00403742
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00403742